We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$304B
AUM Growth
-$14.5B
Cap. Flow
-$11.3B
Cap. Flow %
-3.72%
Top 10 Hldgs %
15.32%
Holding
7,717
New
593
Increased
2,914
Reduced
3,244
Closed
656

Sector Composition

Rank Sector Weight
1 Financials 8.59%
2 Technology 8.45%
3 Healthcare 7.6%
4 Consumer Discretionary 6.86%
5 Energy 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMC icon
6376
United Microelectronic
UMC
$46.9B
$43K ﹤0.01%
20,676
-16,803
-45% -$32.9K
NXGN
6377
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$43K ﹤0.01%
2,800
-4,400
-61% -$66.7K
SRNE
6378
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$43K ﹤0.01%
7,901
+2,857
+57% +$16.6K
CAA
6379
CALL
DELISTED
CalAtlantic Group, Inc.
CAA
$43K ﹤0.01%
1,300
-11,628
-90% -$364K
CYTR
6380
DELISTED
CytRx Corp
CYTR
$43K ﹤0.01%
+2,672
New +$36.5K
KEM
6381
DELISTED
KEMET Corporation
KEM
$43K ﹤0.01%
22,146
-23,914
-52% -$42.1K
ENPH icon
6382
Enphase Energy
ENPH
$5.2B
$42K ﹤0.01%
18,153
-197,997
-92% -$487K
RKDA icon
6383
Arcadia Biosciences
RKDA
$1.44M
$42K ﹤0.01%
19
+4
+27% +$8.5K
XTIA icon
6384
XTI Aerospace
XTIA
$57.3M
0
SODA
6385
CALL
DELISTED
SodaStream International Ltd
SODA
$42K ﹤0.01%
3,000
+1,000
+50% +$13.9K
JMBA
6386
CALL
DELISTED
Jamba, Inc.
JMBA
$42K ﹤0.01%
3,400
-3,400
-50% -$43.3K
BNBX
6387
DELISTED
BNB PLUS CORP
BNBX
0
APPS icon
6388
Digital Turbine
APPS
$1.09B
$41K ﹤0.01%
+34,448
New +$40.7K
BGMS
6389
Bio Green Med Solution Inc
BGMS
$4.86M
0
DBI icon
6390
PUT
Designer Brands
DBI
$331M
$41K ﹤0.01%
1,500
-3,600
-71% -$90.1K
LBTYK icon
6391
CALL
Liberty Global Class C
LBTYK
$3.63B
$41K ﹤0.01%
1,267
-11,866
-90% -$361K
TULP
6392
Bloomia Holdings
TULP
$16M
$41K ﹤0.01%
2,035
+205
+11% +$3.88K
SHOO icon
6393
PUT
Steven Madden
SHOO
$3.48B
$41K ﹤0.01%
+1,650
New +$36.7K
GLOG
6394
PUT
DELISTED
GASLOG LTD
GLOG
$41K ﹤0.01%
4,200
+300
+8% +$2.58K
KATE
6395
PUT
DELISTED
Kate Spade & Company
KATE
$41K ﹤0.01%
+1,600
New +$31.4K
SALE
6396
PUT
DELISTED
RetailMeNot, Inc. Series 1
SALE
$41K ﹤0.01%
5,100
-4,800
-48% -$39.1K
FRO icon
6397
PUT
Frontline
FRO
$8.88B
$40K ﹤0.01%
4,760
-1,860
-28% -$18K
GLNG icon
6398
PUT
Golar LNG
GLNG
$5B
$40K ﹤0.01%
+2,200
New +$37.6K
SABR icon
6399
CALL
Sabre
SABR
$779M
$40K ﹤0.01%
1,400
+1,300
+1,300% +$34.7K
TEX icon
6400
PUT
Terex
TEX
$7.36B
$40K ﹤0.01%
1,600
-10,700
-87% -$224K

Similar funds

Goldman Sachs's Q1 2016 Portfolio in Review

As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.

  • Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
  • Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
  • Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
  • Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
  • Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
  • Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
  • Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.